Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2018 Financial Results on March 13, 2019

CLEARWATER, Fla.–(BUSINESS WIRE)–Apyx Medical Corporation, formerly Bovie Medical Corporation,
(the “Company”), a maker of medical devices and
supplies and the developer of J-Plasma®, a patented surgical
product marketed and sold under the Renuvion® Cosmetic
Technology brand in the cosmetic surgery market, today announced that
financial results for the fourth quarter and fiscal year 2018 will be
released after the market closes on Wednesday, March 13.

Management will host a conference call at 4:30 p.m. Eastern Time on
March 13 to discuss the results of the quarter and to host a question
and answer session. To listen to the call by phone, interested parties
may dial 844-507-6493 (or 647-253-8641 for international callers) and
provide access code 5488443. Participants should ask for the Apyx
Medical Corporation Call. A live webcast of the call will be accessible
via the Investor Relations section of the Company’s website and at:

A telephonic replay will be available approximately two hours after the
end of the call through March 27, 2019. The replay can be accessed by
dialing 800-585-8367 for U.S. callers or 416-621-4642 for international
callers and using the replay access code: 5488443. The webcast will be
archived on the Investor Relations section of the Company’s website.

About Apyx Medical Corporation:

Apyx Medical Corporation (formerly Bovie Medical Corporation) is an
advanced energy technology company with a passion for elevating people’s
lives through innovative products in the cosmetic and surgical markets.
Known for its innovative Helium Plasma Technology, Apyx is solely
focused on bringing transformative solutions to the physicians and
patients it serves. The company’s Helium Plasma Technology is marketed
and sold as Renuvion® in the cosmetic surgery market and
J-Plasma® in the hospital surgical market. Renuvion offers
plastic surgeons, fascial plastic surgeons and cosmetic physicians a
unique ability to provide controlled heat to the tissue to achieve their
desired results. The J-Plasma system allows surgeons to operate with a
high level of precision and virtually eliminating unintended tissue
trauma. The Company also leverages its deep expertise and decades of
experience in unique waveforms through original equipment manufacturing
(OEM) agreements with other medical device manufacturers. For further
information about the Company and its products, please refer to the Apyx
Medical Corporation website at www.ApyxMedical.com.


Westwicke Partners on behalf of Apyx Medical Corporation
Piccinino, CFA

error: Content is protected !!